Delivery of sorafenib by myofibroblast-targeted nanoparticles for the treatment of renal fibrosis
Hui‐Teng Cheng(FIND), Hsi‐Chien Huang(National Tsing Hua University), Yun‐Chieh Sung(The University of Texas Southwestern Medical Center), Pei-Ru Jin(National Tsing Hua University), Kuo‐How Huang(National Taiwan University), Tzu‐Chieh Lin(National Yang Ming Chiao Tung University), I. Pu Juang(University of Pittsburgh), Ling-Hsuan Chen(National Tsing Hua University), Tsung‐Ying Lee(National Tsing Hua University), Yuhui Liao(Kunming Medical University), Kuan‐Wei Huang(University of California Davis Medical Center), Yunching Chen(Kaohsiung Medical University), Yi‐Ting Chen(First Affiliated Hospital Zhejiang University), Cheng‐Han Chao(National Taiwan University Hospital), Yuehua Chen(Harbin Institute of Technology), Jane Wang(National Tsing Hua University), Chi-Ting Su(National Taiwan University Hospital), Yi-Hua Sheng(National Tsing Hua University), Tzu-Chieh Lin(National Yang Ming Chiao Tung University), Shuei-Liong Lin(National Tsing Hua University), Hsueh-Cheng Wang(National Yang Ming Chiao Tung University)
Cited by 31
Related Papers
The MicroRNA Spectrum in 12 Body Fluids
|Clinical Chemistry|2010|2.8k
CXCR4 inhibition in tumor microenvironment facilitates anti‐programmed death receptor‐1 immunotherapy in sorafenib‐treated hepatocellular carcinoma in mice
|Hepatology|2014|456
Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis
|Journal of Clinical Investigation|2014|229
Aristolochic acid‐induced upper tract urothelial carcinoma in Taiwan: Clinical characteristics and outcomes
|International Journal of Cancer|2013|133
Kidney impairment in primary aldosteronism
|Clinica Chimica Acta|2011|133